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A B S T R A C T
Background: Health care workers (HCW) are at high risk of developing physical/mental health outcomes related
to coronavirus syndromes. Nature and frequency of these outcomes are undetermined.
Methods: PRISMA/MOOSE-compliant (PROSPERO-CRD42020180205) systematic review of Web of Science/grey
literature until 15th April 2020, to identify studies reporting physical/mental health outcomes in HCW infected/
exposed to Severe Acute Respiratory Syndrome -SARS-, Middle East Respiratory Syndrome -MERS-, Novel coronavirus
-COVID-19-. Proportion random effect meta-analyses, I2 statistic, quality assessment and sensitivity analysis.
Results: 115 articles were included (n=60,458 HCW, age 36.1±7.1, 77.1% female). Physical health outcomes:
75.9% HCW infected by SARS/MERS/COVID-19 reported fever (95%CI=65.9–83.7%, k=12, n=949), 47.9%
cough (95%CI=39.2–56.8%, k=14, n=970), 43.6% myalgias (95%CI=31.9–56.0%, k=13, n=898), 42.3% chills
(95%CI=20.2–67.9%, k=7, n=716), 41.2% fatigue (95%CI=18.2–68.8%, k=6, n=386), 34.6% headaches
(95%CI=23.1–48.2%, k=11, n=893), 31.2% dyspnoea (95%CI=23.2–40.5%, k=12, n=1003), 25.3% sore throat
(95%CI=18.8–33.2%, k=8, n=747), 22.2% nausea/vomiting (95%CI=14.9–31.8%, k=6, n=662), 18.8% diar-
rhoea (95%CI=11.9–28.4%, k=9, n=824). Mental health outcomes: 62.5% HCW exposed to SARS/MERS/COVID-
19 reported general health concerns (95%CI=57.0–67,8%, k=2, n=2254), 43.7% fear (95%CI=33.9–54.0%,
k=4, n=584), 37.9% insomnia (95%CI=30.9–45.5%, k=6, n=5067), 37.8% psychological distress
(95%CI=28.4–48.2%, k=15, n=24,346), 34.4% burnout (95%CI=19.3–53.5%, k=3, n=1337), 29.0% anxiety
features (95%CI=14.2–50.3%, k=6, n=9191), 26.3% depressive symptoms (95%CI=12.5–47.1%, k=8,
n=9893), 20.7% post-traumatic stress disorder features (95%CI=13.2–31%, k=11, n=3826), 16.1% somatisation
(95%CI=0.2–96.0%, k=2, n=2184), 14.0% stigmatisation feelings (95%CI=6.4–28.1%, k=2, n=411).
Limitations: Limited amount of evidence for some outcomes and suboptimal design in several studies included.
Conclusions: SARS/MERS/COVID-19 have a substantial impact on the physical and mental health of HCW, which
should become a priority for public health strategies.
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1. Introduction
The novel "SARS-CoV-2" or "2019-nCoV" coronavirus disease
(COVID-19) identified in Wuhan is not the first coronavirus to have
quickly spread and caused havoc in the 21st century. The SARS-CoV
identified in Canton (Severe Acute Respiratory Syndrome, SARS
hereby), became the first zoonosis of this century (2002) (Chen et al.,
2006), followed by the MERS-CoV (Middle East Respiratory Syndrome
MERS hereby), identified in 2012 in Saudi Arabia. These three syn-
dromes can be transmitted by mildly ill, pre-symptomatic or asympto-
matic infected individuals (Shah et al., 2020) and are putting health-
care systems under unprecedented pressure (Holmes et al., 2020;
Shah et al., 2020; Xiang et al., 2020). Half of the general population
rated the psychological impact of the COVID-19 outbreak as being
moderate or severe (Wang et al., 2020). However, the World Health
Organisation has identified health care workers (HCW) as a group at
particular risk of developing a wide range of physical/mental problems
as a result of working directly or indirectly with COVID-19 patients
(Koh et al., 2003). HCW are particularly exposed to the threat of
transmission (Huang et al., 2020) because of their frontline work with
patients with high viral loads and suboptimal personal protection
equipment (Christian et al., 2004; Ehrlich et al., 2020; Nam et al.,
2017). At the same time, severe stress, high emotional load, long
working hours, concerns of being infected or infecting their relatives,
lack of adequate support in the working environment and lack of ef-
fective supportive treatments can affect HCW's mental health
(Moazzami et al., 2020; Vieta et al., 2020).
Despite the profound impact of these syndromes on HCW's physical/
mental health, to our knowledge, no systematic review has compre-
hensively appraised the burden (type and frequency) of these outcomes
in the current literature. Profiling the impact of SARS/MERS/COVID-19
on the HCW's health is pivotal to inform detection, monitoring and
preventive/treatment strategies. The current systematic review and
meta-analysis provide the first quantitative evidence synthesis of the
impact of SARS/MERS/COVID-19 on physical and mental health out-
comes of HCW.
2. Methods
This study (study protocol registered on PROSP-
ERO-CRD42020180205) was conducted in accordance with “Preferred
Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA)
(Moher et al., 2009) (eTable I) and “Meta-analyses Of Observational
Studies in Epidemiology” (MOOSE) checklist (Stroup et al., 2000)
(eTable II), following “EQUATOR Reporting Guidelines” (Altman et al.,
2008).
2.1. Search strategy and selection criteria
A systematic literature search was carried out by two independent
researchers (GSP, AC) using the following keywords: “SARS” OR “COV”
OR “coronavirus” OR “MERS” OR “Orthocoronavirinae” OR “Severe
Acute Respiratory Syndrome” OR “Middle East Respiratory Syndrome”
OR "CoV-19” OR “SARS-CoV” OR "SARS-CoV-2” OR "2019 nCoV" OR
“2019nCoV” OR "2019 novel coronavirus" OR "COVID 19" OR "new
coronavirus" OR "novel coronavirus" OR "SARS CoV-2" OR “Wuhan
coronavirus” OR "COVID 19" OR "2019-nCoV" AND “professionals” OR
“worker*” OR “doctor*” OR “nurse*” OR “occupation*” OR “em-
ployee*” OR “healthcare provider*” OR “healthcare worker*” OR
“healthcare employee*” OR “personnel” OR “emergency worker” OR
“paramedic*”. First, Web of Science database (Clarivate Analytics) was
searched, incorporating the Web of Science Core Collection, the BIOSIS
Citation Index, the KCI-Korean Journal Database, MEDLINE®, the
Russian Science Citation Index, and the SciELO Citation Index, from
inception until 15th April 2020. Second, given that this field is rapidly
developing, we searched the preprint servers medRxiv, psyArXiv and
bioRxiv for the terms ‘coronavirus’ or ‘COVID-19’ from 1st January
2020 until 15th April 2020. Third, we searched references from in-
cluded studies and reviews that were screened during the literature
search. We screened articles identified as abstracts, and after excluding
those that did not meet our inclusion criteria, the full texts of the re-
maining articles were assessed for eligibility and decisions made about
their inclusion.
2.2. Condition and individuals being studied
Inclusion criteria for the systematic review were a) individual stu-
dies with primary data (including letters, commentaries, qualitative
studies and conference proceedings) or grey literature, b) focusing on
HCW (including physicians, nurses, trainees and other health profes-
sionals) exposed to or infected by SARS/MERS/COVID-19 (see below),
c) reporting physical or mental health outcomes, d) sample size >5 and
e) written in English. Exclusion Criteria were a) reviews, clinical cases,
or study protocols, b) reporting outcomes on populations other than
HCW, including the general population, c) with sample size ≤5. For the
meta-analysis, additional inclusion criteria were a) reporting meta-
analysable data and b) non-overlapping samples (overlap was de-
termined by looking at the type of population and country in which the
study was carried, and the study with the largest sample was then se-
lected).
2.3. Data extraction
Two researchers (GSP, JVS) independently extracted data from all
the included studies. The two databases were then cross-checked, and
discrepancies were resolved through consensus under the supervision of
a senior researcher (PFP). A summary of selected variables included:
first author and year of publication, country, topic investigated, HCW
category involved, sample size, age (mean± SD), sex (% female),
physical/mental health, data source, quality assessment (see below)
and key findings.
2.4. Risk of bias (quality) assessment
Risk of bias was assessed using a modified version of the Mixed
Methods Appraisal Tool (MMAT) as per protocol (detailed in eMethods
1). MMAT is considered the best and most comprehensive tool available
for appraising multi-method studies (Behghadami et al., 2019).
2.5. Strategy for data synthesis
First, we provided a systematic synthesis (reported in the supple-
mentary material) of the findings from the included studies structured
around physical/mental health outcomes, and type of coronavirus
syndromes (MERS vs SARS vs COVID-19). Second, we performed meta-
analyses using, as primary effect size, the proportion (% and SE) of
physical or mental health outcomes in HCW with a SARS/MERS/
COVID-19 infection or exposed to SARS/MERS/COVID-19 (for details
on the definition of the infection/exposure status see eMethods 2). The
meta-analyses were split across physical and mental health out-
comes—as operationalised by each individual study—and included
both pooled and stratified estimates across SARS vs MERS vs COVID-19.
Heterogeneity among studies was assessed using the Q statistic, with
the proportion of the total variability in effect size estimates evaluated
using the I² index (with an I2>50% representing significant hetero-
geneity) (Lipsey and Wilson, 2000). Random-effect models were em-
ployed as heterogeneity was expected to be high (DerSimonian and
Laird, 1986). Publication biases were not assessed because studies in-
cluded in proportion meta-analyses are non-comparative; thus, there
are no "negative" or "undesirable" results or study characteristics like
significant levels that may have biased publications (Maulik et al.,
2011). We further conducted meta-analytical regression analyses (when
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data were available) to estimate the association between the analysed
outcomes and: (i) sex, (ii) age, (iii) study quality, (iv) professional ca-
tegory (physicians vs nurses vs multi-professional samples) and (v) data
source (self-administered questionnaires/surveys vs interviews/eva-
luations). All analyses were conducted using Comprehensive Meta-
Analysis (CMA) V3 (Borenstein et al., 2013).
3. Results
The literature search yielded 2,925 citations (2,923 through elec-
tronic database searching and 2 through manual search), which were
screened for eligibility; 324 articles were assessed in full text, and 209
were excluded (reasons for exclusion are detailed in eTable III). The
final database for the systematic included 115 studies (Fig. 1): 65
(56.5%) focused on SARS, 26 (22.6%) on MERS and 24 (20.9%) on
COVID-19; 11 (9.6%) were qualitative studies, 3 (2.6%) non-rando-
mised interventional studies and 101 (87.8%) quantitative studies. The
full database included 60,458 HCW (35,905 SARS; 5,246 MERS; 19,307
COVID-19). The total sample size of the included studies ranged from 7
(Almutairi et al., 2018; Memish et al., 2013) to 10,511 (Koh et al.,
2005) HCW (eTable IV-VI). The mean age of the sample was 36.1±7.1
years ranging from 23 (Wong et al., 2004b) to 69.4 (Ran et al., 2020)
years; 77.1% were female. 90 (78.3%) studies included HCW from Asia,
18 (15.7%) HCW from America, 4 (3.5%) from Europe and 3% (2.6%)
from more than one continent. In 64 (55.7%) studies, HCW completed
self-administered questionnaires/surveys; in 51 (44.3%) studies, HCW
were evaluated or interviewed by a professional. Most studies (85;
73.9%) investigated more than one HCW category; 19 studies (16.5%)
focused on nurses, 9 (7.8%) on physicians, 1 (0.9%) on medical stu-
dents and 1 (0.9%) on social workers. Forty studies were included in the
meta-analysis (Fig. 1), focusing on physical health outcomes in HCW
infected by SARS/MERS/COVID-19 and mental health outcomes in
HCW exposed to SARS/MERS/COVID-19 (see eTables IV-VI).
3.1. Physical health outcomes in HCW with SARS/MERS/COVID-19
infection
The top 10 most frequently reported physical health symptoms in
those with SARS/MERS/COVID-19 infection are displayed in Table 1,
Fig. 2 and systematically described in the eTables IV-VI. The meta-
analysis revealed that 75.9% of HCW with SARS/MERS/COVID-19 in-
fection reported fever (95%CI=65.9–83.7%, k=12, n=949), 47.9%
cough (95%CI=39.2–56.8%, k=14, n=970), 43.6% myalgias
(95%CI=31.9–56.0%, k=13, n=898), 42.3% chills
(95%CI=20.2–67.9%, k=7, n=716), 41.2% fatigue
(95%CI=18.2–68.8%, k=6, n=386), 34.6% headaches
(95%CI=23.1–48.2%, k=11, n=893), 31.2% dyspnoea
(95%CI=23.2–40.5%, k=12, n=1003), 25.3% sore throat
Fig. 1. PRISMA 2009 Flow Diagram.
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(95%CI=18.8–33.2%, k=8, n=747), 22.2% nausea/vomiting
(95%CI=14.9–31.8%, k=6, n=662) and 18.8% diarrhoea
(95%CI=11.9–28.4%, k=9, n=824) (Table 1, Fig. 2). Heterogeneity
was statistically significant (I2=70.9–95.9%) and sensitivity analyses
revealed that chills, fatigue and sore throat were more frequent
(p<0.001, p<0.001, p=0.018 respectively) in SARS (73.8%, 80.0%,
28.7% respectively) compared to MERS (30.0%, 25.6%, 24.5% re-
spectively) and COVID-19 (4.5%, 38.0%, 20.7% respectively, Table 1,
Fig. 2).
3.2. Mental health outcomes in HCW exposed to SARS/MERS/COVID-19
The top 10 most frequently reported symptoms in SARS/MERS/
COVID-19 are displayed in Table 2, Fig. 3) and systematically described
in the eTables IV-VI. The meta-analysis revealed that 62.5% HCW ex-
posed to SARS/MERS/COVID-19 reported general health concerns
(95%CI=57.0–67.8%, k=2, n=2254), 43.7% fear
(95%CI=33.9–54.0%, k=4, n=584), 37.9% insomnia
(95%CI=30.9–45.5%, k=6, n=5067), 37.8% psychological distress
(95%CI=28.4–48.2%, k=15, n=24,346), 34.4% burnout
(95%CI=19.3–53.5%, k=3, n=1337), 29.0% anxiety features
(95%CI=14.2–50.3%, k=6, n=9191), 26.3% depressive symptoms
(95%CI=12.5–47.1%, k=8, n=9893), 20.7%, post-traumatic stress
disorder (PTSD) features (95%CI=13.2–31%, k=11, n=3826), 16.1%
somatisation (95%CI=0.2–96.0%, k=2, n=2184) and 14.0% stigma-
tisation feelings (95%CI=6.4–28.1%, k=2, n=411) (Table 1, Fig. 2).
Heterogeneity was substantial (I2=70.2–99.7%) and sensitivity ana-
lyses revealed that PTSD features were more frequent (p<0.001) in
MERS (40.7%) than in SARS (16.7%) and COVID-19 (7.7%, Table 2,
Fig. 3).
3.3. Quality assessment and meta-regressions
The quality of the included studies was 3.2± 0.9 and ranged from 1
to 5. This was 2.3± 0.5 in non-randomised studies, 3.7± 0.6 in qua-
litative studies and 3.2± 0.9 in quantitative descriptive studies
(eTables IV-VI). Female sex was associated with higher prevalence of
myalgias (β=0.041, p=0.001) and sore throat (β=0.035, p=0.004)
(eTable VII). Psychological distress was associated with female sex
(β=0.032, p=0.002), younger age (β=-0.106, p<0.001), and profes-
sional category (β=-2.760, p<0.001): studies including nurses were
associated to higher psychological distress than studies including only
physicians (p<0.001) or including multi-professional samples
(p<0.001) (eTable VIII). No other meta-regressions resulted sig-
nificant.
Table 1
Meta-analytical proportion of physical health outcomes in HCW with SARS/MERS/COVID-19 infection.
Symptom Group No. of
studies
Sample size Random effects model z Score P Test for Heterogeneity Between-group heterogeneity
Proportion 95 % CI Q I2 P Q P
Chills Any coronavirus 7 716 0.423 0.202 0.679 −0.573 0.566 149.675 95.991 <0.001 46.067 <0.001
SARS 4 315 0.738 0.560 0.862 2.558 0.011 16.363 81.666 0.001
MERS 1 283 0.300 0.249 0.356 −4.521 <0.001 <0.001 <0.001 1.000
COVID-19 2 118 0.045 0.019 0.101 −6.832 <0.001 0.117 <0.001 0.733
Cough Any coronavirus 14 970 0.479 0.392 0.568 −0.452 0.651 72.720 82.125 <0.001 2.803 0.246
SARS 5 329 0.368 0.234 0.527 −1.635 0.102 20.764 80.736 <0.001
MERS 4 341 0.487 0.271 0.708 −0.111 0.912 15.340 80.443 0.002
COVID-19 5 300 0.562 0.397 0.715 0.732 0.464 29.397 86.393 <0.001
Diarrhoea Any coronavirus 9 824 0.188 0.119 0.284 −5.332 <0.001 59.340 86.518 <0.001 4.814 0.090
SARS 2 209 0.274 0.083 0.610 −1.343 0.179 3.895 74.326 0.048
MERS 2 315 0.306 0.197 0.443 −2.724 0.006 2.147 53.433 0.143
COVID-19 5 300 0.120 0.054 0.247 −4.441 <0.001 20.664 80.642 <0.001
Dyspnoea Any coronavirus 12 1003 0.312 0.232 0.405 −3.806 <0.001 66.182 83.379 <0.001 5.117 0.077
SARS 4 313 0.330 0.171 0.542 −1.582 0.114 19.851 84.888 <0.001
MERS 3 322 0.538 0.262 0.793 0.250 0.803 15.307 86.934 <0.001
COVID-19 5 368 0.202 0.114 0.331 −4.009 <0.001 21.753 81.612 <0.001
Fatigue Any coronavirus 6 386 0.412 0.182 0.688 −0.609 0.543 96.695 94.829 <0.001 48.167 <0.001
SARS 1 193 0.800 0.738 0.851 7.704 <0.001 <0.001 <0.001 1.000
MERS 2 51 0.256 0.155 0.393 −3.305 0.001 0.315 <0.001 0.575
COVID-19 3 142 0.380 0.153 0.674 −0.789 0.430 18.582 89.237 <0.001
Fever Any coronavirus 12 949 0.759 0.659 0.837 4.595 <0.001 71.019 84.511 <0.001 4.716 0.095
SARS 4 315 0.963 0.763 0.995 3.056 0.002 12.166 75.341 0.007
MERS 3 334 0.671 0.342 0.889 1.021 0.307 15.716 87.274 <0.001
COVID-19 5 300 0.714 0.576 0.820 2.959 0.003 20.445 80.435 <0.001
Headaches Any coronavirus 11 893 0.346 0.231 0.482 −2.211 0.027 118.565 91.566 <0.001 2.933 0.231
SARS 4 313 0.518 0.307 0.723 0.160 0.873 26.797 88.805 <0.001
MERS 3 334 0.274 0.077 0.629 −1.271 0.204 21.756 90.807 <0.001
COVID-19 4 246 0.232 0.071 0.545 −1.704 0.088 47.147 93.637 <0.001
Myalgias Any coronavirus 13 898 0.436 0.319 0.560 −1.013 0.311 106.415 88.723 <0.001 40.447 <0.001
SARS 5 329 0.633 0.542 0.716 2.826 0.005 7.636 47.613 0.106
MERS 4 341 0.409 0.193 0.667 −0.676 0.499 23.126 87.027 <0.001
COVID-19 4 228 0.178 0.042 0.515 −1.885 0.059 48.198 93.776 <0.001
Nausea/
vomits
Any coronavirus 6 662 0.222 0.149 0.318 −5.030 <0.001 22.105 77.380 0.001 1.896 0.387
SARS 2 207 0.276 0.219 0.341 −6.198 <0.001 0.282 <0.001 0.595
MERS 2 315 0.283 0.151 0.467 −2.283 0.022 3.234 69.083 0.072
COVID-19 2 140 0.071 0.008 0.428 −2.211 0.027 5.170 80.657 0.023
Sore throat Any coronavirus 8 747 0.253 0.188 0.332 −5.539 <0.001 24.034 70.874 0.001 8.075 0.018
SARS 2 209 0.287 0.117 0.549 −1.613 0.107 4.584 78.187 0.032
MERS 3 334 0.245 0.202 0.294 −8.825 <0.001 0.618 <0.001 0.734
COVID-19 3 204 0.207 0.079 0.443 −2.365 0.018 14.175 85.890 0.001
COVID-19: novel coronavirus 19; MERS: Middle East Respiratory Syndrome; SARS: Severe Acute Respiratory Syndrome.
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4. Discussion
To the best of our knowledge, this is the first systematic review to
have comprehensively addressed the impact of SARS/MERS/COVID-19
on both physical and mental health of HCW. With 115 individual stu-
dies and 60,458 individuals included and several outcomes in-
vestigated, this study demonstrated that SARS/MERS/COVID-19 have a
substantial impact on HCW's physical and mental health.
Fig. 2. Top 10 Most frequently reported physical health outcomes in HCW with SARS/MERS/COVID-19 infection.
Table 2
Meta-analytical proportion of mental health outcomes in HCW exposed to SARS/MERS/COVID-19
Symptom Group No. of
studies
Sample size Random effects model z Score P Test for Heterogeneity Between-group
heterogeneity
Proportion 95 % CI Q I2 P Q P
Psychological
distress
Any coronavirus 15 24346 0.378 0.284 0.482 −2.293 0.022 2572.027 99.456 <0.001 1.102 0.576
SARS 10 17144 0.409 0.293 0.536 −1.406 0.160 1358.872 99.338 <0.001
MERS 2 413 0.323 0.216 0.453 −2.638 0.008 2.235 55.249 0.135
COVID-19 3 6789 0.299 0.089 0.652 −1.13 0.258 780.733 99.744 <0.001
Anxiety features Any coronavirus 6 9191 0.290 0.142 0.503 −1.935 0.053 1318.346 99.621 <0.001 0.557 0.456
SARS 2 1475 0.457 0.051 0.930 −0.122 0.903 214.086 99.533 <0.001
COVID-19 4 7716 0.222 0.127 0.358 −3.660 <0.001 329.839 99.090 <0.001
PTSD features Any coronavirus 11 3826 0.207 0.132 0.310 −4.851 <0.001 390.38 97.438 <0.001 22.741 <0.001
SARS 7 2570 0.167 0.126 0.220 −9.354 <0.001 51.138 88.267 <0.001
MERS 3 786 0.407 0.199 0.656 −0.722 0.470 82.561 97.578 <0.001
COVID-19 1 470 0.077 0.056 0.105 −14.355 <0.001 <0.001 <0.001 1.000
Depressive
symptoms
Any coronavirus 8 9893 0.263 0.125 0.471 −2.212 0.027 1898.27 99.631 <0.001 1.153 0.283
SARS 4 2177 0.368 0.126 0.701 −0.761 0.447 478.474 99.373 <0.001
COVID-19 4 7716 0.179 0.067 0.401 −2.659 0.008 791.154 99.621 <0.001
Insomnia Any coronavirus 6 5067 0.379 0.309 0.455 −3.079 0.002 134.201 96.274 <0.001 0.999 0.317
SARS 3 1577 0.295 0.107 0.593 −1.369 0.171 102.890 98.056 <0.001
COVID-19 3 3490 0.445 0.382 0.509 −1.685 0.092 29.322 93.179 <0.001
Burnout Any coronavirus 3 1337 0.344 0.193 0.535 −1.61 0.107 67.959 97.057 0.000 0.964 0.326
SARS 2 1305 0.382 0.195 0.613 −1.001 0.317 65.953 98.484 <0.001
COVID-19 1 32 0.250 0.130 0.426 −2.691 0.007 0.000 1.000 <0.001
Stigmatisation
feelings
Any coronavirus 2 411 0.140 0.064 0.281 −4.073 0.000 8.816 88.658 0.003 N.a.
SARS 2 411 0.140 0.064 0.281 −4.073 0.000 8.816 88.658 0.003
Fear Any coronavirus 4 584 0.437 0.339 0.540 −1.196 0.232 11.813 74.603 0.008 1.217 0.270
SARS 3 557 0.416 0.311 0.530 −1.446 0.148 9.874 79.744 0.007
MERS 1 27 0.540 0.355 0.714 0.415 0.678 <0.001 <0.001 1.000
General health
concern
Any coronavirus 2 2254 0.625 0.570 0.678 4.341 0.000 3.351 70.161 0.067 N.a.
SARS 2 2254 0.625 0.570 0.678 4.341 0.000 3.351 70.161 0.067
Somatisation Any coronavirus 2 2184 0.161 0.002 0.960 −0.672 0.502 334.981 99.701 <0.001 N.a.
SARS 2 2184 0.161 0.002 0.960 −0.672 0.502 334.981 99.701 <0.001
COVID-19: novel coronavirus 19; MERS: Middle East Respiratory Syndrome; PTSD: post-traumatic stress disorder; SARS: Severe Acute Respiratory Syndrome.
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This meta-analysis identified for the first time the most frequent
physical health outcomes in HCW infected by SARS/MERS/COVID-19.
Fever was the most frequent symptom in HCW (75.9%); it was more
frequent in the general population with COVID-19 infection (meta-
analyses: 85.6–88.7% (Hu et al., 2020; Li et al., 2020a; Rodriguez-
Morales et al., 2020; Zhu et al., 2020)) and similarly frequent in the
general population with MERS infection (meta-analysis: 77%
(Badawi and Ryoo, 2016)). Cough appeared slightly less frequently in
HCW (47.9%) than in the general population with COVID-19 infections
(meta-analyses: 57.6–68.6% (Hu et al., 2020; Li et al., 2020a;
Rodriguez-Morales et al., 2020; Zhu et al., 2020)). Conversely, myalgias
in HCW (43.6%) were more frequent than in the general population
with COVID-19 infections (meta-analyses: myalgia/fatigue=35.8%
(Li et al., 2020a); muscle soreness=33% (Zhu et al., 2020)). Our sen-
sitivity analyses found that chills (42.3% across all SARS/MERS/
COVID-19) were more frequent in HCW with SARS (73.8%) than MERS
(30.0%) and particularly COVID-19 (4.5%) infection; frequency of
chills in HCW with SARS infection was comparable to the general po-
pulation (SARS: 74.0–75.5% (Liu et al., 2003; Tiwari et al., 2003)).
Frequency of fatigue in HCW (41.2%) was also comparable to the
general population with COVID-19 infection (meta-analyses:
42.4–46.1% (Hu et al., 2020; Zhu et al., 2020)). Furthermore, in the
general population, fatigue appears more frequently in SARS (60-70%
(Huo et al., 2003; Xu et al., 2003)) than in COVID-19 (meta-analyses:
42.4–46.1% (Hu et al., 2020; Zhu et al., 2020)), in line with our sen-
sitivity analyses (fatigue in HCW: SARS=80.0%, MERS=25.6%,
COVID-19=38.0%). Frequency of dyspnoea in HCW (31.2%) was
comparable (Hu et al., 2020; Li et al., 2020a; Rodriguez-Morales et al.,
2020; Zhu et al., 2020) to the general population with COVID-19 in-
fection (meta-analyses: 21.4–45.6% (Hu et al., 2020; Rodriguez-
Morales et al., 2020; Zhu et al., 2020)) but lower than in the general
population with MERS infection (meta-analysis: 68% (Badawi and
Ryoo, 2016)). Frequency of headaches (34.6%), nausea/vomiting
(22.2%) and diarrhoea (18.8%) in HCW were as frequent as in the
general population with COVID-19 infection (meta-analyses:
headaches=8–15.4% (Rodriguez-Morales et al., 2020; Zhu et al.,
2020); nausea/vomiting=3.9–10.2% (Li et al., 2020a; Zhu et al.,
2020); diarrhoea=4.8-12.9% (Cheung et al., 2020; Li et al., 2020a;
Rodriguez-Morales et al., 2020; Zhu et al., 2020)). Frequency of sore
throat (25.3%) was similar between HCW and the general population
infected by COVID-19 (meta-analysis: 11.0–21.9% (Li et al., 2020a;
Rodriguez-Morales et al., 2020)), but lower than in the general popu-
lation affected with MERS (meta-analysis: 39% (Badawi and
Ryoo, 2016)). However, while our sensitivity analyses found a higher
prevalence of sore throat in HCW with SARS (28.7%) compared to
COVID-19 infection (20.7%), this effect was not observed in the general
population (SARS: 13–25% (Hui et al., 2003), COVID-19 11.0–21.9%
(Li et al., 2020a; Rodriguez-Morales et al., 2020)).
Whether these differences are due to differential reporting of
symptoms by HCW or by a specific clinical course of these syndromes
remains unclear. However, since the meta-regressions revealed that
findings were not affected by the type of data source, it is possible to
speculate that differences in the frequency of symptoms may char-
acterise specific clinical manifestations of SARS/MERS/COVID-19 in
HCW. The repeated exposure to high viral loads from contaminated
patients (Liu et al., 2020) can interact with high environmental
stress—which is known to affect the immune system (Troyer et al.,
2020)—and theoretically account for some of these findings. Overall,
the impact of SARS/MERS/COVID-19 infection on the physical health
of HCW is profound, to the point that it has been identified as the most
common cause of death for physicians during the outbreak (Li et al.,
2020b), particularly general practitioners and emergency department
physicians (Ing et al., 2020).
This is also the first meta-analysis that is specifically addressing
mental health outcomes in HCW exposed to SARS/MERS/COVID-19. As
global public health concerns, general health concerns represent the
most frequent issue in HCW (62.5% according to our results) and a
main topic in the general population (Hamid et al., 2020; Nickell et al.,
2004; Paudel et al., 2020). In some vulnerable groups as pregnant
women, general health concerns cumulate to 94.6% (Du et al., 2020).
Fig. 3. Top 10 Most frequently reported mental health outcomes in HCW exposed to SARS/MERS/COVID-19.
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General health concerns are typically high when the outbreak starts
(80.3%), intensify even further over its course (up to 88.6%) and de-
cline (75.4%) once the acute phase has resolved (Ro et al., 2017).
During pandemics/epidemics, fear of contracting coronaviruses has
often been associated with psychological distress (Shacham et al.,
2020). Accordingly, fear (43.7%) was the second most frequent mental
health issue in HCW, although less common than in the general popu-
lation during SARS epidemic (individual studies: 60–70% (Bener and
Al-Khal, 2004; Chen et al., 2004; Yip et al., 2007)), possibly because of
higher health literacy in HCW (Al Sayah et al., 2013). While the fre-
quency of psychological distress in HCW (37.8%) was similar to that
observed in the general population (SARS:39% (DiGiovanni et al.,
2004)), our meta-regression analyses found that psychological distress
was particularly common in HCW subgroups (see below). Frequency of
poor sleep during a COVID-19 outbreak was 18.2% in the general po-
pulation (Huang and Zhao, 2020), about half of what we observed in
HCW (37.9%). This may be due to long shifts and working hours that
typically characterise HCW's clinical duties during epidemics/pan-
demics (Puliatti et al., 2020). A frequently associated feature was
burnout—already high in ordinary times for HCW (Adriaenssens et al.,
2015)—which peaked to 34.4% in HCW exposed to SARS/MERS/
COVID-19; burnout is reported to be particularly high in nurses
working long hours with MERS patients (Kim and Choi, 2016). Level of
burnout is hardly ever reported or evaluated in the general population,
but it has been related to physical distance from the epicentre of pan-
demic/epidemic outbreaks, with an inverted U-shaped relationship
(Zhang et al., 2020a). Our meta-analysis also showed a higher fre-
quency of anxiety (29.0%) and depressive (26.3%) features in HCW
compared to the general population with SARS/MERS infection (meta-
analyses: depression=15% (Rogers et al., 2020); anxiety dis-
orders=14.8% (Rogers et al., 2020)), although the current meta-ana-
lysis was not restricted to categorical diagnoses. Furthermore, the SARS
outbreak has resulted in historically high suicide rates in the general
population (Cheung et al., 2008; Yip et al., 2010); suicide cases related
to COVID-19 have been already reported, also in HCW (Jun et al.,
2020). However, it is not known how risk of suicide is in HCW com-
pared to the general population.
Although the frequency of PTSD features in HCW exposed to SARS/
MERS/COVID-19 appeared lower (20.7%) than in the general popula-
tion with SARS/MERS infection (meta-analysis: PTSD=32.5%
(Rogers et al., 2020)), PTSD symptoms usually appear months after the
traumatic experience, and it may be too early in the case of COVID-19
pandemic. In fact, mental health in SARS was found to be more im-
paired in the phase following the acute outbreak than in the initial
phase (Chong et al., 2004). Future research should evaluate a potential
increase in PTSD symptoms in HCW exposed to COVID-19 after the
present study. An alternative explanation is that HCW may have fewer
risk factors for PTSD, such as a history of physical diseases or a family
history of psychiatric disorders (Tortella-Feliu et al., 2019). Our sensi-
tivity analyses showed that— among HCW— PTSD features were more
frequent in MERS (40.7%) than in SARS (16.7%) and COVID-19 (7.7%);
this could relate to the higher levels of trauma associated with the
overall higher mortality rates of MERS (Ahmed, 2017) in the general
population (MERS=35% (Yan et al., 2020)-41% (Ahmed, 2017); SARS
9.6% (Yan et al., 2020)- 21% (Chang et al., 2020); COVID-19 2%
(Yan et al., 2020)-5% (Li et al., 2020a)). HCW also experience higher
levels of somatisation (16.1%) than the general population (0.4%)
(Zhang et al., 2020b). Finally, 14.0% of HCW reported having stigma-
tisation feelings, albeit less frequently than the general population
(39.5%) (DiGiovanni et al., 2004); some HCW expressed that people
avoided not only them, due to their job, but also their families
(Koh et al., 2005).
Overall, the findings of the current study may have some clinical
implications. First, they clearly confirm that HCW are as essential as a
fragile population which is put under high physical and mental health
burden during SARS/MERS/COVID-19. Although HCW´s dedication
and commitment outweigh the risk and their willingness to fight SARS/
MERS/COVID-19 (Aldrees et al., 2017; Hussein, 2004; Imai et al.,
2005), HCW recognise to be at risk, mostly because of the lack of
personal protective equipment (Iacobucci, 2020), high working pres-
sure (Bai et al., 2020; Lung et al., 2009; Shih et al., 2007) and sub-
optimal training/confidence when working in extreme circumstances
(Hsu et al., 2006). Second, these findings inform the detection and re-
cognition of core physical and mental health outcomes in HCW during
SARS/MERS/COVID-19 epidemics/pandemics. Given the logistic chal-
lenges of conducting research during infective outbreaks, focusing on
the most frequent outcomes that are reported in HCW may represent a
pragmatic advantage. For example, the vast majority of HCW (77%)
were females, and our meta-regressions demonstrated that female HCW
were more frequently displaying myalgias and sore throat, while young
HCW, females and nurses were particularly vulnerable to SARS/MERS/
COVID-19-related psychological distress. These findings can be used to
develop gender/age- (or professional group-) sensitive guidelines for
recognising the physical and mental health burden of these syndromes.
In fact, some professional bodies are already developing specific re-
commendations for vulnerable categories such as pregnant HCW
women (who are at risk of complications themselves and their neonates
(Khan et al., 2020)), older HCW or HCW with a history of chronic
diseases (Kowalski et al., 2020). While the physical health of HCW is
more frequently monitored, the current findings may guide healthcare
providers and policymakers to implement systematic screenings for
HCW's mental health. Third, the current findings can be used to design
or refine preventive approaches. Services for individuals at Clinical
High Risk for Psychosis (Fusar-Poli et al., 2020; Kotlicka-Antczak et al.,
2020; Salazar de Pablo et al., 2019) may leverage our findings to refine
preventive approaches. For example, there is emerging evidence that
Covid-19 may increase the incidence of short-lived psychotic episodes
(Anmella et al., 2020; Valdés-Florido et al., 2020; Zulkifli et al., 2020)
also termed as brief and limited intermittent psychotic symptoms
(Castagnini and Fusar-Poli, 2017; Fusar-Poli et al., 2016; Fusar-
Poli et al., 2017; Fusar-Poli et al., 2019; Minichino et al., 2019;
Rutigliano et al., 2018). Our review found that HCW presented with
full-blown disorders as acute stress disorder (Bai et al., 2004) or PTSD
(Lee et al., 2018). Outside HCW, severe mental disorders have been
detected after coronavirus syndromes (Rogers et al., 2020). This evi-
dence suggests that monitoring for emerging mental disorders should
become a cornerstone of preventive care during pandemics. Preventive
approaches may include education programmes targeting HCW to in-
form them about their risk of developing specific physical/mental
health outcomes while providing direct or indirect care to SARS/MERS/
COVID-19 patients. HCW may be particularly reluctant to disclose their
problems (Chen et al., 2020; Shanafelt et al., 2020) to minimise the
burden on their relatives (Chen et al., 2020) or because they over
consider themselves self-reliant (Shanafelt et al., 2020). Because the
current study concurrently appraises both physical and mental health
outcomes, it is particularly suited to inform cross-cutting approaches
such as interventions designed to enhance resilience and therefore
impact both physical and mental health (Maunder et al., 2008). It may
be possible to screen those HCW at a high risk of developing psychiatric
disorders using instruments that have been validated to detect emer-
ging severe mental disorders (Fusar-Poli et al., 2020), such as the
Comprehensive Assessment of At Risk Mental States (Yung et al., 2005),
the Structured Interview for Bipolar At Risk States (Fusar-Poli et al.,
2018) and the PredictD (King et al., 2008). New screening instruments
are being validated to identify individuals with mental health concerns
in the general population with specific reference to the current COVID-
19 pandemic (Lee, 2020). These approaches could be extended to all
categories which this review found to be impacted by SARS/MERS/
COVID-19: physicians (Grace et al., 2005), nurses (Su et al., 2007),
health care assistants (Poon et al., 2004), students (Wong et al., 2004a),
social workers (Gearing et al., 2007) and trainees (Rambaldini et al.,
2005). Fourth, the current findings can serve as real-world targets to
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inform the development of effective treatments for restoring the im-
paired physical health and mental health of HCW, which are currently
limited. Globally, substantial research investments are being deployed
to establish effective treatments for physical and mental health out-
comes in HCW, in particular leveraging the potential of eHealth and
telemedicine during epidemics/pandemics (Moazzami et al., 2020;
Whaibeh et al., 2020; Williamson et al., 2020).
This study has several limitations. First, despite our comprehensive
approach, there was a limited amount of evidence to provide stratified
results for the proportion of stigma, general health concern and so-
matisation in HCW exposed to MERS or COVID-19. Also, some emer-
ging symptoms that have only recently been detected in the general
population such as anosmia were not extensively reported in HCW, thus
preventing their inclusion in the current meta-analysis. Second, het-
erogeneity was substantial in the evaluated outcomes. We conducted
meta-analytical regression analyses to evaluate the influence of several
variables on our results. Third, despite our meta-regressions, we were
unable to quantify the impact of ethnic, clinical and treatment factors,
or healthcare system differences, which may act as confounding factors.
Forth, HCW exposed to SARS/MERS/COVID-19 may also have been
infected but be asymptomatic, and infection status may have gone
unnoticed by researchers. Also, it may not have been possible to detect
all the symptoms that appeared in HCW. These are intrinsic limitations
of the underlying primary research. Fifth, we excluded studies not
published in English. This may have resulted in the exclusion of some
studies, particularly from Asian countries. However, we were able to
detect 115 individual studies with our approach, 90 of which were
conducted in Asia. Sixth, the main symptoms of SARS in general po-
pulation have not been subjected to a comprehensive meta-analysis,
limiting comparative analyses with our results. Finally, because of the
challenges in conducting research during a pandemic, several studies
had a suboptimal design; the data source was controlled in meta-re-
gression analyses revealing no impact on the results.
5. Conclusions
SARS/MERS/COVID-19 have a substantial impact on the physical
and mental health of HCW, which should become a priority for public
health strategies.
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